Crown BioScience

Activities: Research & Development

Trending Articles

  1. OINDPs: Nosey about recent developments? OINDPs are a user friendly and efficacious alternative to injectables in several disease areas
  2. Transforming healthcare with patient centricity In this opinion article, John Kytariolos, Head of Clinical and Scientific Affairs at Adragos Pharma, discusses patient-centric dosage forms, their properties and the impact...
  3. Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222 Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
  4. Compact process thermostat for efficient temperature control in the laboratory The temperature control system is designed for the accurate temperature control of small research reactors between -40 to +200 °C
  5. AviadoBio expands presence at Canary Wharf The company has acquired 11,000 sqft of laboratory and office space in Canary Wharf to accommodate the growing team

Upcoming event

Making Pharmaceuticals

23–24 April 2024 | Exhibition | Coventry, UK See all

Related Content

Finance

JSR Life Sciences companies form Japanese joint venture

Based in Tokyo, the venture will establish a local team led by an experienced General Manager, Hiroki Itou
Research & Development

Crown Bioscience opens oncology biomarker R&D centre in California

New custom-designed 32,000 sqft facility in San Diego to support the growth of both oncology biomarker and inflammation service portfolios
Research & Development

Crown Bioscience and Charles River agree to expand access to ZDSD rat model

The agreement enables greater global model availability for drug discovery in obesity, diabetes and metabolic syndrome
Research & Development

Crown Bioscience creates Center of Excellence for bioinformatics, big data and biomarker discovery

Services and capacity increase with new site opening
Research & Development

Crown Bioscience expands cardiovascular and metabolic disease research capability

The company offers new non-GLP services and translational rodent models at its expanded site in Louisiana
Research & Development

CrownBio expands humanised models for targeted immunotherapy

The humanised model expansion programme will begin with PD-1, CTLA-4 and CD137 models
Research & Development

Grant awarded to doctors researching innovative PDX models in immuno-oncology

Crown Bioscience awarded Dr Lavial and his colleagues the grant due to their project's potential to create breakthroughs in preclinical oncology strategies
Subscribe now